PubMed Health⌕ Search

Biomedical subjects

S Zimmo

Publications and source records attributed to S Zimmo.

5 recordsLinked to original sources

Alexandrite laser hair removal is safe for Fitzpatrick skin types IV-VI.

BACKGROUND: Various lasers have been developed for epilation of unwanted hair. Most studies, however, have been done in white patients with minimal reference to dark-skinned individuals. OBJECTIVE: To determine the safety profile of a long-pulsed alexandrite laser for hair removal in patients with Fitzpatrick skin types IV-VI exclusively. METHODS: Prospective clinical evaluation conducted from June 1998 to April 1999 at a referral private clinic. Prelaser skin testing was performed starting at 16 J/cm2 and energy fluence selected according to response. Complications were recorded at each visit. RESULTS: One hundred and fifty patients are reported (18 men and 132 women) ranging in age from 15 to 50 years, for a total of 550 treatment sites. Complications occurred in only 2% of cases. CONCLUSION: The long-pulsed alexandrite laser is safe for hair removal in darker skin tones. Prelaser skin testing was not helpful in this study, as there was no relationship between skin reaction and the incidence of complications.

Adolescent↗

Prevalence of antibody to hepatitis D virus among HBsAg-positive drug-dependent patients in Jeddah, Saudi Arabia.

Over a period of ten months, all the patients admitted for drug dependence were tested for HBsAg. The positive cases were tested for anti-HDV. The anti-HDV-positive patients were further tested for liver function tests (LFTs) and anti-HCV. A total of one thousand three hundred and twenty one patients were tested. Out of this, 1038 were intravenous drug users (IDUs) and 283 were non-IDUs. Eighty one patients were HBsAg positive (75 IDUs and six non-IDUs). Eleven patients were anti-HDV positive--all were IDUs. The overall prevalence of anti-HDV among HBsAg-positive patients was 13.6%. Among HBsAg-positive IDUs, it was 14.7% and it was 0.0% for HBsAg-positive non-IDUs. Nine (81.8%) of the eleven anti-HDV-positive patients were also positive for anti-HCV and eight (72.7%) had abnormal LFTs. In view of the association of hepatitis B, C and D viruses with chronic liver disease recommendations have been made to control the spread of these viruses and to prevent liver disease.

Adolescent↗

Prevalence of antibodies to hepatitis C virus in drug-dependent patients in Jeddah, Saudi Arabia.

The prevalence of antibodies to hepatitis C virus (anti-HCV) in a population of intravenous drug users in Jeddah, Saudi Arabia was 74.6%. The anti-HCV prevalence in drug dependent patients who did not use the intravenous route was 10.5%. The anti-HCV prevalence in healthy Saudi males and in healthy non-Saudi's was 1.7% and 3.2% respectively. There is a need for public education to control the spread of the virus.

Adolescent↗

Desert dermatology.

Explore the source record for details and available documents.

Afghanistan↗

The prevalence of human immunodeficiency virus among drug-dependent patients in Jeddah, Saudi Arabia.

This study was carried out to determine the prevalence of HIV among drug-dependent patients in Jeddah. Between January 1 1995 and May 31 1996, all the patients admitted into the Al Amal Hospital for drug dependence were screened for HIV by Enzyme Immunoassay (EIA) and confirmed by Western blot. Those positive by the two tests were questioned about exposure to the risk factors for HIV infection and examined for clinical evidence of Acquired Immunodeficiency Syndrome (AIDS). Of 2628 admitted, 5 tested positive by EIA but only 4 were confirmed by Western blot, giving an overall prevalence of 0.15%. Three of the four HIV carriers used the intravenous route for drug use and the calculated prevalence for 2102 intravenous drug users was 0.14%. None of the patients showed any clinical evidence of AIDS. In view of the known preference by drug-dependent patients in Jeddah for the parenteral route and their sharing of needles and syringes, recommendations are made to prevent the spread of HIV through this group and into the community.

Adult↗